Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
10
×
national blog main
san francisco
10
×
san francisco blog main
10
×
san francisco top stories
startups
10
×
life sciences
biotech
national top stories
boston blog main
boston top stories
new york blog main
new york top stories
vc
investing
san diego blog main
san diego top stories
software
artificial intelligence (a.i.)
detroit blog main
detroit top stories
entrepreneurship
financing
funding
gene therapy
hardware
healthcare
innovation
internet
investor
medical device
medical devices
mobile
raleigh-durham blog main
roboticsai
web
wireless
wisconsin blog main
wisconsin top stories
10x genomics
What
startup
big
companies
deal
based
bio
biotech
business
expand
firm
francisco
help
life
lung
medical
million
san
software
tech
therapy
today
ability
acquire
acquired
admits
ago
aiming
ambys
analytics
announced
appleton
array
auris
available
babies
betterdoctor
biosciences
biotechs
boost
building
Language
unset
Current search:
deals
×
" san francisco blog main "
×
" san francisco "
×
startups
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Quest Analytics Buys Healthcare Compliance Software Firm BetterDoctor
@xconomy.com
6 years ago
Fictiv Raises $15M To Connect Tech Innovators & Parts Manufacturers
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed